2.Clinical application of combined detection of serum tumor markers in diagnosis of lung cancer
Chinese Journal of Primary Medicine and Pharmacy 2013;20(18):2775-2776
Objective To investigate the significance of combined detection of serum tumor markers in the diagnosis of lung cancer,and to select the most sensitive serum tumor markers.Methods Enzyme-linked immunosorbent assay was used to detect the serum tumor markers of 62 lung cancer patients and 62 healthy persons,who were neuron specific enolase enzyme (NES),carbohydrate antigen 125 (CA 125),cytokeratin 19 (CYFRA21-1) and carcinoembryonic antigen(CEA).Results The level of serum CEA,CA125,CYFRA21-1,and NES of the lung cancer group were all higher than those of the control group (all P < 0.05).Among the four kinds of tumor markers,CA125 had the highest sensitivity(59.7%),which was followed by CEA(53.2%).The sensitivity of the four kinds of joint detection was 87.1%,the highest sensitivity of three markers joint detection was CEA + CA125 + CYFRA21-1 (87.1%),while that of the two kinds of joint detection was CEA + CA125 (75.8%).Conclusion There are high clinical significance in the diagnosis of lung cancer with four kinds of serum tumor markers,CEA + CA125 + CYFRA21-1 can be used as the best markers for joint detection of lung cancer with high sensitivity.
4.CHANGES OF PLASMA IMMUNOREACTIVE ?-ENDORPHIN LEVEL IN NIDDM AND ITS RELATIONSHIP WITH CHRONIC COMPLICATIONS
Chinese Journal of Endocrinology and Metabolism 1986;0(04):-
Plasma concentrations of immunoreactivc beta-endorphin in patients with NIDDM were measured by radioimmuno-assay. It was found that the plasma beta-endorphin levels decreased in 68 cases of NIDDM especially in those with long duration of illness and chronic complication. These results suggested that beta-endorphin may be related to diabetes and its chronic complication.
5.THE RELATIONSHIP OF IMMUNOREACTIVE ?-ENDORPHIN LEVELS IN HYPOTHALAMUS, PITUITARY AND PANCREAS OF DIABETIC RATS AND THE COURSE OF DISEASE
Jing WANG ; Jia-Qingdept ZHANG ;
Chinese Journal of Endocrinology and Metabolism 1986;0(03):-
Immunoreactive beta-endorphin was measured by radioimmunoassay (RIA) in the pituitary, hypothalamus, pancreas and plasma of female diabetic rats induced by streptozotocin. In addition, pain threshold was determined. The results showed that the concentrations of beta-endorphin in pituitary, hypothalamus, pancreas and plasma began to decrease on the first month after being made diabetic. Then, the levels of beta-endorphin continued to decrease significantly as the course progressed, especially in pancreas and plasma. Diabetic rats consistently showed a decreased pain threshold after 4 weeks. These results suggested that the decrease of beta-endorphin may be related to the course of diabetes and pain threshold.
6.Effect of traumatic occlusion on the expression of OPG and RANKL mRNA in the rat alveolar bone
Hangdong ZHANG ; Hongchen LIU ; Jing JIA
Medical Journal of Chinese People's Liberation Army 1981;0(06):-
Objective To investigate the expression change of receptor activator of NF ?B ligand (RANKL) and osteoprotegerin (OPG) mRNA in rat alveolar bone and the possible mechanism of alveolar bone resorption under traumatic occlusion. Methods Thirty SD rats weighed 270g?20g were used and divided into 6 groups, of which one group was as control. A square wire thickened about 1mm was bonded with Super bond composite resin on to the occlusal surface of left upper first molar of the rats in experiment groups. The animals were executed after 1,3,7,14,28 days. The left jaw were processed for the study of the expression of RANKL and OPG mRNA with RT PCR. Results Expression of RANKL and OPG mRNA in alveolar bone was significantly different between experiment and control groups. During occlusal trauma, expression of RANKL and OPG mRNA enhanced in 1 day group. The ratio of RANKL/OPG mRNA expression raised in 1、14 and 28 day groups. Conclusion The ratio of RANKL/OPG mRNA expression changed during occlusion trauma. RANKL and OPG might be involved in the restructure of periodontal tissue after traumatic occlusion
7.Limit Test for Camphor in Shujin Huoxue Pills
Zhengfeng ZHANG ; Jia WU ; Jing XIE
Herald of Medicine 2015;(7):950-951,952
Objective To establish a method for limit test of camphor in Shujin Huoxue pills. Methods A DB-WAX (30 m×0. 32 mm,0. 25 μm) capillary column was used with a programmed temperature. Results The linear range of camphor was 1. 05-210. 00 μg·mL-1(r=1. 0). The average recovery was 101. 7%(n=9, RSD=1. 2%). Conclusion The proposed method is simple, sensitive, accurate and reproducible, which is suitable for quality control of Shujin Huoxue Pills.
8.Centralized cancer pain cognition situation in basic medical staff from China
Jing LIU ; Jing WANG ; Yuming JIA ; Kaijian LEI ; Yao ZHANG ; Jian JIANG ; Jingjing GUO ; Fengqin JIA
Chinese Journal of Clinical Oncology 2013;(24):1509-1511
Objective:To understand the recognition status of cancer pain in basic medical staff from small towns to provide the basis for the improvement of cancer pain management in these areas. Methods:The medical staff of Hengjiang Town and subordinate villages was selected. The study area is situated in southwest China. Centralized questionnaires regarding cancer pain were collected and analyzed. A program and education of cancer pain were provided for these medical workers. Results: The medical staff from Hengjiang asserted that only 17%of cancer pain patients receive treatments. Approximately 70%of the medical staff did not consider the popularization and explanation of cancer pain treatment in their patients. Approximately 64%of the medical staff was not familiar with standardized cancer pain control, 87%did not believe that narcotics could suffice the need of patients, and 44%did not participate in the training for cancer pain control. Conclusion: The medical staff in Hengjiang possesses less knowledge on the importance of cancer pain. Hence, further training is necessary. The specific management of cancer pain as a part of community chronic diseases is mandatory.
9.Cardiac protection of prostacyclin secreted from endothelial progenitor cells against oxidative stress-induced apoptosis:verified by cardiac electrophysiological tests
Jing ZHANG ; Lu RUAN ; Li KANG ; Xiaohai CUI ; Jia ZHANG
Chinese Journal of Tissue Engineering Research 2016;20(20):2949-2956
BACKGROUND:Prostacyclin (PGI2) and its analogs have been reported to prevent pressure overload-induced cardiac hypertrophy, and to reduce cardiac ischemia/reperfusion injury. However, clinical application of PGI2 is chalenging due to its short half-life (< 2 minutes). Thus, we have generated PGI2 expressing rat endothelial progenitor cel strains (PGI2-EPCs) that constitutively secrete prostacyclin.
OBJECTIVE:To investigate the protective effectof PGI2-EPCs against oxidative stress-induced cardiomyocyte injury.
METHODS:Cultured H9c2 celsin vitrowere assigned into four groups: H9c2 cels treated by H2O2for 4 hours. H9c2 cels were pretreated by conditioned medium (colected form EPCs and PGI2-EPCs or colected form EPCs and PGI2-EPCs mixed with native EPCs) before the addition of H2O2. PBS instead of conditioned mediums served as negative control. The paracrine effect of PGI2-EPCs onin vitro angiogenesis of native EPCs was evaluated. MTT and Hoechst 33342 assays were used to examine the protective effect of conditioned medium on H2O2-induced rat embryonic cardiomyocyte apoptosis and cel viability. Finaly, the effect of conditioned medium on the electric activities of adult cardiomyocyteswas measuredby whole-cel patch clamp techniques.
RESULTS AND CONCLUSION:When native EPCs mixed with conditioned medium of PGI2-EPCs, the total length of tubes was significantly longer compared with those mixed with CM of EPC. Rat embryonic cardiomyocytes pretreated with conditioned medium of PGI2-EPCs significantly reduced H2O2-induced apoptosis and preserved cel viability compared with pretreatment with EPC-conditioned medium and without pretreatment (P< 0.01). Pretreatment of rat adult cardiomyocyteswith conditioned medium of PGI2-EPCs abolished H2O2-induced early afterdepolarization and shortened H2O2-induced action potential duration prolongation (P< 0.01) towards baseline.Our findings indicate thatPGI2-EPCs protect against oxidative stress-induced cardiomyocyte injury through paracrine action.ThisStudy providesthe groundwork for an innovative cel therapy approach to treat ischemic heart disease.
10.Research progress on cardio-protective drug for preventing anthracycline cardiotoxicity
Jingkun QU ; Jia ZHANG ; Jing ZHANG ; Jiansheng WANG
Chinese Journal of Clinical Oncology 2014;(22):1474-1477
Anthracyclines, which include doxorubicin, epirubicin, daunorubicin, and aclarubicin, are widely used chemotherapeu-tic agents for treating hematologic and solid tumors, such as acute leukemia, lymphoma, breast cancer, gastric cancer, soft tissue sarco-mas, and ovarian cancer. Anthracyclines can be combined with other chemotherapeutics and molecular targeted drugs for cancer treat-ment. The combination of anthracyclines with other chemotherapeutic drugs is usually the standard of first-line treatment. Anthracy-clines are efficacious and potent agents with broad antitumor effects. However, these drugs may cause adverse reactions, such as hair loss, myelotoxicity, and cardiotoxicity. Hematopoietic stimulating factors, such as granulocyte colony-stimulating factor, erythropoietin, and thrombopoietin, can be used to control myelotoxicity. However, cardiotoxicity is the most serious anthracycline side effect. Clinical study results and practical observations indicate that the anthracycline cardiotoxicity is usually progressive and irreversible, especially after the first use of the drug, which may particularly cause heart damage. Therefore, the early detection and prevention of anthracy-cline-induced cardiotoxicity are important and have already gained considerable attention in clinical applications. Relevant experts from the China Society of Clinical Oncology and Hematology Branch of the Chinese Medical Association prepared the guidelines for the pre-vention and cure of anthracycline-induced cardiotoxicity in 2013. The authors reviewed the effective drugs currently used to prevent and cure anthracycline cardiotoxicity.